Jafry Syed A. 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Jun 2, 2025

Form 4

Period: 2025-05-29

Director

Transactions

Award
Restricted Stock Units
2025-05-29+1,404.798→ 7,580.726 total
→ Common Stock (1,404.798 underlying)
Award
Phantom Stock Units
2025-05-29+810.46→ 6,975.435 total
Exercise: $92.54→ Common Stock (810.46 underlying)

Footnotes (6)

[F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
[F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F3]These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
[F4]Includes 14.439 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F5]The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
[F6]Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Documents

1 file